TrialPanorama/TrialPanorama-database huggingface dataset:
Study 29996726 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 29996892 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 29996892 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 29997897 — Predictive Biomarker (PRD): DCC mRNA
Genes: DCC; IGDCC1
Study 29998370 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 30001986 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 30001986 — Predictive Biomarker (PRD): TET2 mRNA
Genes: TET2; KIAA1546; Nbla00191
Study 30001986 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 30001986 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-C
Genes: HLA-JY3, D6S204, PSORS1
Study 30001987 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 30002113 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 30002483 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 30002483 — Predictive Biomarker (PRD): LDLR mRNA
Genes: LDLR
Study 30002483 — Predictive Biomarker (PRD): LRP1 mRNA
Genes: LRP1; A2MR; APR
Study 30002483 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30002864 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30004628 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 30004628 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 30004628 — Predictive Biomarker (PRD): TGFBR2 mRNA
Genes: TGFBR2
Study 30004628 — Predictive Biomarker (PRD): ETS1 mRNA
Genes: ETS1; EWSR2
Study 30004628 — Safety Biomarker (SAF): miR-128
Study 30004820 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 30005640 — Surrogate Endpoint (SUR): Serum creatinine
Study 30006326 — Surrogate Endpoint (SUR): Blood pressure
Study 30006616 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 30009185 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 30009894 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30010022 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 30010028 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 30010028 — Surrogate Endpoint (SUR): Blood pressure
Study 30010906 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 30012100 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study 30012100 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study 30012324 — Predictive Biomarker (PRD): CSF1 mRNA
Genes: CSF1
Study 30012324 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study 30012869 — Surrogate Endpoint (SUR): Blood pressure
Study 30012869 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30012869 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 30013821 — Surrogate Endpoint (SUR): Blood pressure
Study 30016313 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study 30016392 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 30016415 — Surrogate Endpoint (SUR): Blood pressure
Study 30017884 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 30018134 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 30018811 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 30018814 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 30018815 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 30021548 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study 30021706 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 30021845 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30023287 — Surrogate Endpoint (SUR): Bone mineral density
Study 30025081 — Predictive Biomarker (PRD): RPE65 mRNA
Genes: RPE65
Study 30026059 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 30026784 — Predictive Biomarker (PRD): BAAT mRNA
Genes: BAAT
Study 30028037 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 30029674 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30030617 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 30031399 — Predictive Biomarker (PRD): HAS2 mRNA
Genes: HAS2
Study 30031399 — Safety Biomarker (SAF): Pentraxin-related protein PTX3
Genes: PTX3; TNFAIP5; TSG14
Study 30031399 — Predictive Biomarker (PRD): GDF9 mRNA
Genes: GDF9
Study 30031700 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30032306 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study 30032814 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 30033738 — Predictive Biomarker (PRD): CD200 mRNA
Genes: CD200; MOX1; MOX2; My033
Study 30033738 — Safety Biomarker (SAF): MMP-1
Genes: MMP1
Study 30035000 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 30038390 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 30038669 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 30038669 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 30039554 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study 30039554 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 30040065 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 30041608 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 30041626 — Predictive Biomarker (PRD): C1QL1 mRNA
Genes: C1QL1; C1QRF; CRF; CTRP14
Study 30041685 — Surrogate Endpoint (SUR): Blood pressure
Study 30041962 — Predictive Biomarker (PRD): CCL20 mRNA
Genes: CCL20; LARC; MIP3A; SCYA20
Study 30042144 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 30044692 — Predictive Biomarker (PRD): MYD88 mRNA
Genes: MYD88
Study 30044693 — Predictive Biomarker (PRD): IKZF1 mRNA
Genes: IKZF1; IK1; IKAROS; LYF1; ZNFN1A1
Study 30044695 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study 30045838 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study 30045932 — Predictive Biomarker (PRD): IL15 mRNA
Genes: IL15
Study 30046307 — Predictive Biomarker (PRD): KISS1R mRNA
Genes: KISS1R; AXOR12; GPR54
Study 30046988 — Surrogate Endpoint (SUR): Blood pressure
Study 30050529 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 30051724 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30052269 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 30053231 — Surrogate Endpoint (SUR): Serum creatinine
Study 30053671 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 30053671 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 30053905 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 30053953 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 30054122 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30055562 — Surrogate Endpoint (SUR): Blood pressure
Study 30055804 — Surrogate Endpoint (SUR): Serum calcium
Study 30055837 — Predictive Biomarker (PRD): CEP290 mRNA
Genes: CEP290; BBS14; KIAA0373; NPHP6
Study 30055837 — Predictive Biomarker (PRD): AHI1 mRNA
Genes: AHI1
Study 30055837 — Predictive Biomarker (PRD): INPP5E mRNA
Genes: INPP5E
Study 30055837 — Predictive Biomarker (PRD): MKS1 mRNA
Genes: MKS1
Study 30055837 — Predictive Biomarker (PRD): NPHP1 mRNA
Genes: NPHP1; NPH1
Study 30056391 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 30057766 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 30057766 — Surrogate Endpoint (SUR): Blood pressure
Study 30058068 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 30058349 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 30058572 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 30060061 — Predictive Biomarker (PRD): CCND1
Genes: U21B31
Study 30060751 — Monitoring Biomarker (MOI): Procalcitonin
Study 30061811 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study 30062662 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study 30064841 — Predictive Biomarker (PRD): IDE mRNA
Genes: IDE
Study 30065100 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 30067493 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 30067754 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30067754 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 30067922 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 30068263 — Predictive Biomarker (PRD): IRF4 mRNA
Genes: IRF4; MUM1
Study 30068263 — Predictive Biomarker (PRD): PRDM1 mRNA
Genes: PRDM1; BLIMP1
Study 30068263 — Predictive Biomarker (PRD): XBP1 mRNA
Genes: XBP1; TREB5; XBP2
Study 30068505 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 30070030 — Predictive Biomarker (PRD): FAAH2 mRNA
Genes: FAAH2; AMDD
Study 30071865 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 30072107 — Predictive Biomarker (PRD): CCL17 mRNA
Genes: CCL17; SCYA17; TARC
Study 30072107 — Predictive Biomarker (PRD): CCL18 mRNA
Genes: CCL18; AMAC1; DCCK1; MIP4; PARC; SCYA18
Study 30072107 — Predictive Biomarker (PRD): CXCL13 mRNA
Genes: CXCL13; BCA1; BLC; SCYB13
Study 30072107 — Predictive Biomarker (PRD): CXCL14 mRNA
Genes: CXCL14; MIP2G; NJAC; SCYB14; PSEC0212; UNQ240/PRO273
Study 30072107 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study 30072107 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Matrix metalloproteinase 3
Genes: MMP3; STMY1
Study 30072107 — Predictive Biomarker (PRD): MMP7 mRNA
Genes: MMP7; MPSL1; PUMP1
Study 30072107 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study 30072203 — Surrogate Endpoint (SUR): Bone mineral density
Study 30073261 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 30073261 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 30073261 — Monitoring Biomarker (MOI): Cell-free DNA
Study 30073432 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 30073642 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 30073642 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study 30073642 — Predictive Biomarker (PRD): POLE mRNA
Genes: POLE; POLE1
Study 30073642 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 30074111 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 30075751 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 30075808 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30077125 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 30077990 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30081867 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 30081937 — Predictive Biomarker (PRD): CTLA4
Genes: CD152; CD; GSE; CTLA-4
Study 30081937 — Predictive Biomarker (PRD): SCPEP1 mRNA
Genes: SCPEP1; RISC; SCP1; MSTP034; UNQ265/PRO302
Study 30081937 — Predictive Biomarker (PRD): ID1 mRNA
Genes: ID1; BHLHB24; ID
Study 30082475 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study 30082489 — Predictive Biomarker (PRD): MAX mRNA
Genes: MAX; BHLHD4
Study 30084943 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study 30086261 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30086774 — Predictive Biomarker (PRD): DOCK3 mRNA
Genes: DOCK3; KIAA0299; MOCA
Study 30086778 — Predictive Biomarker (PRD): SLC12A3 mRNA
Genes: SLC12A3; NCC; TSC
Study 30086778 — Surrogate Endpoint (SUR): Blood pressure
Study 30087028 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 30087028 — Predictive Biomarker (PRD): TBK1 mRNA
Genes: TBK1; NAK
Study 30087028 — Predictive Biomarker (PRD): MAP2K2 mRNA
Genes: MAP2K2; MEK2; MKK2; PRKMK2
Study 30087093 — Surrogate Endpoint (SUR): Blood pressure
Study 30087850 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study 30087850 — Predictive Biomarker (PRD): TFF1 mRNA
Genes: TFF1; BCEI; PS2
Study 30088161 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 30088198 — Predictive Biomarker (PRD): HLA-DMB mRNA
Genes: HLA-DMB; DMB; RING7
Study 30088198 — Safety Biomarker (SAF): HLA-DQB1
Genes: IDDM1; CELIAC1
Study 30088198 — Safety Biomarker (SAF): HLA-DRB1
Genes: HLA-DR1B
Study 30088198 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-B
Genes: AS
Study 30089118 — Surrogate Endpoint (SUR): Serum creatinine
Study 30089568 — Surrogate Endpoint (SUR): Blood pressure
Study 30089568 — Surrogate Endpoint (SUR): Serum potassium
Study 30091207 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study 30091600 — Predictive Biomarker (PRD): XIAP mRNA
Genes: XIAP; API3; BIRC4; IAP3
Study 30093147 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 30093503 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study 30093503 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study 30093503 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 30093531 — Predictive Biomarker (PRD): DRD2 mRNA
Genes: DRD2
Study 30093531 — Safety Biomarker (SAF): DRD2
Study 30094070 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 30096071 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 30096071 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 30097433 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 30097433 — Predictive Biomarker (PRD): TNFSF10 mRNA
Genes: TNFSF10; APO2L; TRAIL
Study 30097433 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 30097477 — Monitoring Biomarker (MOI): Mitochondrial frataxin
Genes: FXN; FRDA; X25
Study 30097477 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study 30097706 — Surrogate Endpoint (SUR): Blood pressure
Study 30099268 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study 30099396 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study 30099532 — Surrogate Endpoint (SUR): Blood pressure
Study 30099818 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 30101351 — Predictive Biomarker (PRD): PROM1 mRNA
Genes: PROM1; PROML1; MSTP061
Study 30102205 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 30102789 — Surrogate Endpoint (SUR): Bone mineral density
Study 30102967 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30103979 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 30104186 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 30105951 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 30110589 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 30111326 — Predictive Biomarker (PRD): FHL5 mRNA
Genes: FHL5; ACT
Study 30111365 — Surrogate Endpoint (SUR): Blood pressure
Study 30111609 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 30112005 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30113663 — Predictive Biomarker (PRD): DYRK1A mRNA
Genes: DYRK1A; DYRK; MNB; MNBH
Study 30113663 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SYNPO2 mRNA
Genes: SYNPO2
Study 30113663 — Safety Biomarker (SAF): Nicotinamide phosphoribosyltransferase
Genes: NAMPT; PBEF; PBEF1
Study 30113663 — Predictive Biomarker (PRD): KLF10 mRNA
Genes: KLF10; TIEG; TIEG1
Study 30113663 — Predictive Biomarker (PRD): COL1A1 mRNA
Genes: COL1A1
Study 30113663 — Predictive Biomarker (PRD): MAP2K6 mRNA
Genes: MAP2K6; MEK6; MKK6; PRKMK6; SKK3
Study 30113844 — Predictive Biomarker (PRD): TYK2 mRNA
Genes: TYK2
Study 30113844 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 30115541 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 30115596 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 30115734 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 30116539 — Surrogate Endpoint (SUR): Forced vital capacity
Study 30117761 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 30117761 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 30118852 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 30118942 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 30120161 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 30120161 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 30120281 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 30120281 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 30121271 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 30121419 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 30121602 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 30123846 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30123846 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 30124008 — Surrogate Endpoint (SUR): Forced vital capacity
Study 30124968 — Predictive Biomarker (PRD): GNAS mRNA
Genes: GNAS; GNAS1
Study 30125215 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 30126352 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study 30126361 — Predictive Biomarker (PRD): CPE mRNA
Genes: CPE
Study 30126709 — Surrogate Endpoint (SUR): Serum creatinine
Study 30126765 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 30127037 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study 30127037 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 30127621 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 30128164 — Predictive Biomarker (PRD): KCNK3 mRNA
Genes: KCNK3; TASK; TASK1
Study 30128316 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 30128496 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study 30134368 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study 30135031 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 30135256 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 30137406 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 30137406 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 30138550 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study 30138687 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study 30138764 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 30138764 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 30138764 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 30139368 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 30139779 — Predictive Biomarker (PRD): CXCR2 mRNA
Genes: CXCR2; IL8RB
Study 30139897 — Surrogate Endpoint (SUR): Blood pressure
Study 30142422 — Pharmacodynamic Biomarker (PDY): Mitochondrial membrane potential
Study 30143474 — Predictive Biomarker (PRD): Ribonucleoside-diphosphate reductase large subunit
Genes: RRM1; RR1
Study 30144422 — Predictive Biomarker (PRD): CCL21 mRNA
Genes: CCL21; SCYA21; UNQ784/PRO1600
Study 30144422 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 30144422 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 30144803 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 30144818 — Surrogate Endpoint (SUR): Pathological complete response
Study 30149145 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 30150316 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 30152888 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 30154193 — Predictive Biomarker (PRD): TLR9
Genes: CD289
Study 30154228 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 30155282 — Safety Biomarker (SAF): Hyaluronic acid
Study 30155496 — Surrogate Endpoint (SUR): Probing pocket depth
Study 30156984 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 30156984 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 30157791 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 30157791 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 30158288 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 30158840 — Surrogate Endpoint (SUR): Serum creatinine